Crossmark

Combining network pharmacology and experimental verification to explore the inhibitory effects of Deoxyelephantopin (DET) Against Non-Small Cell Lung Cancer (NSCLC)

Crossref DOI link: https://doi.org/10.1186/s12885-025-14066-3

Published Online: 2025-04-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Shenjia

Guo, Ying

Wang, Rong
License Information

Text and Data Mining valid from 2025-04-21

Version of Record valid from 2025-04-21
More Information

Article History

Received: 4 October 2024

Accepted: 1 April 2025

First Online: 21 April 2025

Declarations

:

: The animal experiments involved in this study have been reviewed and approved by the Biomedical Ethics Committee of Fuyang Normal University.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below